Growing up bipolar: ‘Nobody was on my side’

Jennifer Konjoian was 10 years old when she put a plastic bag over her head. She remembers doing it impulsively, for no other reason than to get attention.

Forest Laboratories, Inc. And Gedeon Richter Plc Announce Results From A Phase II Study Of Cariprazine For The …

Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc. today announced preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of bipolar depression. Cariprazine is currently undergoing Phase III trials for separate indications of schizophrenia and bipolar mania. A total of 233 patients were …

Are mood swings a sign of depression?

Is it possible to have mood swings where one moment you are happy, then the next you can be sad? Is this a sign of depression? I do also have ADD as well but currently am not on medicine.

‘Lovable guy’ was bipolar, family says of Visalia shooter from Modesto

Family members describe two sides of 47-year-old Kenneth James Ward of Modesto. He was a veteran of the Persian Gulf War, a doting father to his 6-year-old son and a lovable brother to his siblings.

Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch” list for depression treatment

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover’s list of the “Top 10 Most Interesting Neuroscience Projects to Watch.”

Forest, Gedeon say drug fails midstage study

Forest Laboratories Inc. and Gedeon Richter PLC said Monday their potential bipolar depression treatment cariprazine did non meet key goals in a midstage study.

Forest-Gedeon Richter drug misses overall goal

TEL AVIV (MarketWatch) — Forest Laboratories Inc. and Gedeon Richter PLC said Monday that in a Phase II study of cariprazine, a potential treatment for bipolar depression, the overall result for patients taking the drug was not statistically different from that of the patients taking placebo. In higher doses, however, the antipsychotic drug did show “evidence of a clinically relevant treatment …

Forest Laboratories announces cariprazine Phase II clinical trial result for bipolar depression treatment

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of bipolar depression. Cariprazine is currently undergoing Phase III trials for separate indications of schizophrenia and bipolar mania.

Calendar

MARK YOUR CALENDARS The Bubba Can Cook Freedom Festival will be Sept. 11 at the Grimes County Expo Center. The cost is $10 for the IBCA-sanctioned cookoff, which will benefit Grimes County seniors and youth. Entertainment includes Max Stalling, Hone …

Uncovered: Help falls short for Maine’s mentally ill

A $100,000 grant will help re-establish some services so uninsured patients can avoid crises and the ER.

Next Page »